YC-1 [3-(5 '-hydroxymethyl-2 '-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G(0)-G(1) in human hepatocellular carcinoma cells

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 藥學院 > 藥物化學研究所 > 期刊論文 > Item 310903500/31011

請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/31011

題名:	YC-1 [3-(5 '-hydroxymethyl-2 '-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G(0)-G(1) in human hepatocellular carcinoma cells
作者:	Wang, SW;Pan, SL;Guh, JH;Chen, HL;Huang, DM;Chang, YL;Kuo, SC;Lee, FY;Teng, CM
貢獻者:	藥學院藥化所;Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei 10764, Taiwan;Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan;Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan;China Med Univ, Grad Inst Pharmaceut Chem, Taichung, Taiwan;Yung Shin Pharmaceut Ind Co Ltd, Taichung, Taiwan
日期:	2005
上傳時間:	2010-09-24 15:09:45 (UTC+8)
出版者:	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
摘要:	Object. The author sought to investigate the temporal changes of postsympathectomy compensatory hyperhidrosis and recurrent sweating in patients with primary palmar hyperhidrosis. Methods. The author examined 91 consecutive patients for this prospective 6-year study. The patients were interviewed at least twice during a 6-month interval; the first follow up was conducted at a median of 1.7 years after surgery (range 2.5-60.5 months). Overall, 24 patients (26.4%) were followed for more than 2 years. Attention was focused on patient satisfaction and the incidence of compensatory hyperhidrosis and recurrent sweating. The overall mean patient satisfaction rate was 78%, with a median 80% improvement on a visual analog scale from 0% (poor) to 100% (excellent). Overall, 88 patients (96.7%) developed compensatory hyperhidrosis, with the mean initial occurrence at 8.2 weeks. The symptoms of compensatory hyperhidrosis progressively worsened to the maximum degree within another 2 weeks after onset (mean 10.3 +/- 1.83 weeks). In 19 patients (21.6%), symptoms of compensatory hyperhidrosis improved spontaneously within 3 months after sympathectomy (mean 13.3 weeks). Postoperative compensatory hyperhidrosis occurred in 71.4% of patients within the 1st year. Recurrent sweating occurred in only 17.6% of patients. None of these patients required repeated operation. The earliest onset of recurrent sweating was noted at 2 weeks postoperatively by three patients, and the mean initial postoperative reccurrence was 32.7 weeks after surgery. Conclusions. Compensatory hyperhidrosis and recurrent sweating are normal thermoregulatory responses that occurred after upper thoracic sympathectomy. Compensatory hyperhidrosis was more prevalent and developed earlier than recurrent sweating. The severity of both compensatory hyperhidrosis and recurrent sweating symptoms remained stable 6 months after surgery.
關聯:	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 312(3):917-925
顯示於類別:	[藥物化學研究所] 期刊論文

文件中的檔案:

沒有與此文件相關的檔案.

在CMUR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....